Programming Thermoresponsiveness of NanoVelcro Substrates Enables Effective Purification of Circulating Tumor Cells in Lung Cancer Patients

Citations Over TimeTop 10% of 2014 papers

Abstract

Unlike tumor biopsies that can be constrained by problems such as sampling bias, circulating tumor cells (CTCs) are regarded as the "liquid biopsy" of the tumor, providing convenient access to all disease sites, including primary tumor and fatal metastases. Although enumerating CTCs is of prognostic significance in solid tumors, it is conceivable that performing molecular and functional analyses on CTCs will reveal much significant insight into tumor biology to guide proper therapeutic intervention. We developed the Thermoresponsive NanoVelcro CTC purification system that can be digitally programmed to achieve an optimal performance for purifying CTCs from non-small cell lung cancer (NSCLC) patients. The performance of this unique CTC purification system was optimized by systematically modulating surface chemistry, flow rates, and heating/cooling cycles. By applying a physiologically endurable stimulation (i.e., temperature between 4 and 37 °C), the mild operational parameters allow minimum disruption to CTCs' viability and molecular integrity. Subsequently, we were able to successfully demonstrate culture expansion and mutational analysis of the CTCs purified by this CTC purification system. Most excitingly, we adopted the combined use of the Thermoresponsive NanoVelcro system with downstream mutational analysis to monitor the disease evolution of an index NSCLC patient, highlighting its translational value in managing NSCLC.

Related Papers

• → Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis(2020)152 cited
• → Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions(2015)71 cited
• → Combination of microfluidic chips and biosensing for the enrichment of circulating tumor cells(2022)30 cited
• → Exploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy(2020)19 cited
• → Clinical Applications of Circulating Tumor Cells in Pharmacotherapy: Challenges and Perspectives(2017)16 cited